Amicus Raises $50 Million In Capital (FOLD)

Amicus Therapeutics, Inc. (NASDAQ: FOLD) has raised more than $50 million in a secondary offering of common stock.  The company sold 10 million shares at a price of $5.70 per share, down from the $5.96 close on Thursday and versus a 52-week trading range of $2.10 to $8.12.

Leerink Swann and Cowen and Company were the underwriters for the offering and Amicus has granted the underwriters a 30-day overallotment option to purchase up to an additional 1,500,000 shares of common stock.

All of the shares are being sold by the company.

This is a rather large offering in size as Yahoo! Finance had the closing value pegged at $206 million before the effects of any new stock on the market.

Today’s offering is on the heels of a big pop earlier in the week, which ultimately did not hold, up to as high as $6.40.